[go: up one dir, main page]

AR011775A1 - Proceso para el aislamiento de eteres y oxima azabiciclo de alta pureza z, en un solo recipiente - Google Patents

Proceso para el aislamiento de eteres y oxima azabiciclo de alta pureza z, en un solo recipiente

Info

Publication number
AR011775A1
AR011775A1 ARP980100342A ARP980100342A AR011775A1 AR 011775 A1 AR011775 A1 AR 011775A1 AR P980100342 A ARP980100342 A AR P980100342A AR P980100342 A ARP980100342 A AR P980100342A AR 011775 A1 AR011775 A1 AR 011775A1
Authority
AR
Argentina
Prior art keywords
isomer
separation
high purity
isolation
zabicycle
Prior art date
Application number
ARP980100342A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR011775A1 publication Critical patent/AR011775A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)

Abstract

Es posible aislar en forma simple las oximas azabiciclo O-sustituidas biologicamente activas que poseen la configuracion Z, (ya que estos isomerosno son activos), sin necesidad de efectuar una separacion por cromatografía, y obtener altosre ndimientos y pureza E/Z mediante la union de un 1-azabiciclo-3-ona de formula (I), donde n= 1 o 2, y donde la configuracion estereoquímica es R, S, o R/S cuando n es 1; con una hidroxilamina O-sustituidade formula (II), donde R es arilo oheter oarilo, en solucion acuosa acídica. Del mismo modo, se puede efectuar la conversion de un isomero configurado E aun isomero Z sin necesidad de realizar una purificacion o separacion. La neutralizacion y la subsiguiente aislacion dela base libre, seguida por laprecipitacion de la sal permite la separacion del isomero Z con alta pureza Z/E. Los productos son agonistas muscarínicos y poseen utilidad para eltratamiento de trastornos cognoscitivos, incluyendo demencia senil detipo Alzheimer.
ARP980100342A 1997-01-27 1998-01-26 Proceso para el aislamiento de eteres y oxima azabiciclo de alta pureza z, en un solo recipiente AR011775A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3597797P 1997-01-27 1997-01-27

Publications (1)

Publication Number Publication Date
AR011775A1 true AR011775A1 (es) 2000-09-13

Family

ID=21885887

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100342A AR011775A1 (es) 1997-01-27 1998-01-26 Proceso para el aislamiento de eteres y oxima azabiciclo de alta pureza z, en un solo recipiente

Country Status (21)

Country Link
US (1) US6121459A (es)
EP (1) EP1021446A1 (es)
JP (1) JP2001511127A (es)
KR (1) KR20000070464A (es)
AR (1) AR011775A1 (es)
AU (1) AU741566B2 (es)
BR (1) BR9714469A (es)
CA (1) CA2270884A1 (es)
CO (1) CO5011092A1 (es)
GT (1) GT199800019A (es)
HR (1) HRP980040B1 (es)
IL (1) IL129793A (es)
MY (1) MY132840A (es)
NZ (1) NZ335784A (es)
PA (1) PA8445601A1 (es)
PE (1) PE75499A1 (es)
SV (1) SV1998000003A (es)
TW (1) TW533215B (es)
UY (1) UY24857A1 (es)
WO (1) WO1998032758A1 (es)
ZA (1) ZA98618B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5583592B2 (ja) 2007-11-30 2014-09-03 ニューリンク ジェネティクス コーポレイション Ido阻害剤
FR2938534B1 (fr) 2008-11-14 2012-10-26 Sanofi Aventis Procede de preparation de l'hemifumarate d'eplivanserine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158015A (en) * 1978-08-16 1979-06-12 Mobil Oil Corporation Process for the stereoselective synthesis of the E isomer of aryl alkyl oximes
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
AU2782792A (en) * 1991-10-15 1993-05-21 Warner-Lambert Company Azabicyclo oxime and amine cholinergic agents and methods of treatment
DE4203170A1 (de) * 1992-02-05 1993-08-12 Basf Ag Verfahren zur herstellung von e-oximethern von phenylglyoxylsaeureestern
IL107881A0 (en) * 1992-12-05 1994-04-12 Fisons Corp Furanone derivatives and pharmaceutical compositions containing them
US5514812A (en) * 1994-06-10 1996-05-07 Warner-Lambert Company Preparation of stereochemically pure oximes with muscarinic activity

Also Published As

Publication number Publication date
JP2001511127A (ja) 2001-08-07
US6121459A (en) 2000-09-19
AU5806598A (en) 1998-08-18
HRP980040A2 (en) 1998-10-31
MY132840A (en) 2007-10-31
CA2270884A1 (en) 1998-07-30
IL129793A (en) 2003-01-12
NZ335784A (en) 2000-12-22
PA8445601A1 (es) 2000-05-24
CO5011092A1 (es) 2001-02-28
GT199800019A (es) 1999-07-20
TW533215B (en) 2003-05-21
IL129793A0 (en) 2000-02-29
AU741566B2 (en) 2001-12-06
BR9714469A (pt) 2000-05-16
ZA98618B (en) 1998-07-30
WO1998032758A1 (en) 1998-07-30
PE75499A1 (es) 1999-08-20
UY24857A1 (es) 1998-06-25
HRP980040B1 (en) 2002-10-31
KR20000070464A (ko) 2000-11-25
EP1021446A1 (en) 2000-07-26
SV1998000003A (es) 1998-08-13

Similar Documents

Publication Publication Date Title
Kagan et al. Photochemistry with circularly polarized light. Synthesis of optically active hexahelicene
ES8207120A1 (es) Un procedimiento para la preparacion de nuevos derivados transisomericos de 4-fenil-1,2,3,4-tetrahidro-1-naftalenami-na.
DE69424940D1 (de) Synthese zyklischer peptide
EA200200016A1 (ru) Способ получения чистого циталопрама
ES2096933T3 (es) Compuesto capaz de permanecer en la region intracerebral y utilizacion del mismo.
KR970703342A (ko) 아자비시클릭 유도체의 제조 방법(Process for The Preparation of Azabicyclic Derivatives)
AR005391A1 (es) Procedimiento para la separación de racematos del tramadol.
MX9302279A (es) Metodo para la produccion del factor viii presenteen el plasma, altamente purificado.
JPS5629551A (en) Preparation of optically active threo-3- 3,4- dihydroxyphenyl serine
AR011775A1 (es) Proceso para el aislamiento de eteres y oxima azabiciclo de alta pureza z, en un solo recipiente
RU94046012A (ru) Способ стереоспецифического гидролиза производных пиперидиндиона, продукт гидролиза и способ получения пароксетина
AR035808A1 (es) Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
AR014738A1 (es) Nuevo procedimiento de preparacion de la fexofenadina y compuestos intermediarios
ES8207505A1 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos
ES2183860T3 (es) Procedimiento para producir n-terc butil-2-pirazincarboxamida y n-ter-butil-2-piperazincarboxamida.
AR013876A1 (es) Un procedimiento para la produccion de acido clavulanico y sales farmaceuticamente aceptables del mismo
AR247723A1 (es) Nuevo procedimiento para preparar acido 4-amino-5-hexenoico y nuevo compuesto intermedio producido por este procedimento
ES8504174A1 (es) Un procedimiento para la preparacion de derivados de pirazolo-quinolinas.
CA2112981A1 (fr) Procede de preparation des isomeres optiques d'un derive de l'amino-2 naphtyridine
ATE61346T1 (de) Synthese von 3s, 4s-boc-statin.
RU94041832A (ru) Удаление катализатора из хлоропрена путем обработки оксикислотой
JPS5325521A (en) Preparation of pantethine
PE43198A1 (es) Proceso para la preparacion de clorhidrato de n-monometil-l-arginina (clorhidrato de l-nmma)
GB899386A (en) d-2-phenyl-3-methyltetrahydro-1,4-oxazine and a method of manufacturing same
RU93001121A (ru) Способ получения очищенной 2,4-дихлорфеноксиуксусной кислоты

Legal Events

Date Code Title Description
FA Abandonment or withdrawal